TETT-STIM: Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation

Sponsor
University Hospital, Tours (Other)
Overall Status
Completed
CT.gov ID
NCT02584894
Collaborator
(none)
39
2
51.4

Study Details

Study Description

Brief Summary

The aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary reactivation of personal traumatic memories with neuromodulation of the right dorsolateral prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.

Condition or Disease Intervention/Treatment Phase
  • Device: rTMS 1Hz
  • Device: rTMS 10Hz
  • Behavioral: psychoneurological assessment
  • Device: conductivity meter
  • Device: electrocardiogram
N/A

Detailed Description

Post-Traumatic Stress Disorder (PTSD) is characterized by intrusive and persistent memory of past result from an event causing or able to cause death, be a threat of death, a severe injury or constitute a threat for physical integrity. It is a frequent disorder in general population (8%). In France, The most frequent traumatic events causing PTSD are serious accidents, rape, physical assaults, violence, etc. PTSD treatment involves antidepressant and cognitive and behavioural psychotherapy, which encourage exposure to elements that remind the trauma (memories, circumstances), with the objective of reducing the fear associated with the traumatic memories. Innovative therapeutic strategies aim to improve the psychotherapeutic effect with enhancement drugs or using neuromodulatory techniques, such as repeated transcranial magnetic stimulation (rTMS).

The aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary reactivation of personal traumatic memories with neuromodulation of the right dorsolateral prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
39 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation : A Control Randomized Study
Actual Study Start Date :
Jan 4, 2016
Actual Primary Completion Date :
Apr 17, 2020
Actual Study Completion Date :
Apr 17, 2020

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: rTMS 1Hz

Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 1Hz on dorsolateral prefrontal cortex (1Hz rTMS is describe in the literature to have no effect on the dorsolateral prefrontal cortex). psychoneurological assessment. Electrodermal conductance measure With conductivity meter . Heart rate measure With electrocardiogram

Device: rTMS 1Hz
trauma exposure + repeated transcranial magnetic stimulation at 1Hz

Behavioral: psychoneurological assessment
psychoneurological assessment

Device: conductivity meter
electrodermal conductance measure

Device: electrocardiogram
heart rate measure

Experimental: rTMS 10Hz

Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 10Hz on dorsolateral prefrontal cortex (10Hz rTMS is describe in the literature to have effect on the dorsolateral prefrontal cortex). psychoneurological assessment. Electrodermal conductance measure With conductivity meter. Heart rate measure with electrocardiogram

Device: rTMS 10Hz
trauma exposure + repeated transcranial magnetic stimulation at 10Hz

Behavioral: psychoneurological assessment
psychoneurological assessment

Device: conductivity meter
electrodermal conductance measure

Device: electrocardiogram
heart rate measure

Outcome Measures

Primary Outcome Measures

  1. Change from baseline Score at Clinician administered PTSD scale [inclusion ; 1 months; 3 months]

    Score at Clinician administered PTSD scale

Secondary Outcome Measures

  1. Change from baseline Score at PTSD Checklist (self-assessment) [inclusion ; 1 month; 3 months]

    Score at PTSD Checklist (self-assessment) for severity of PTSD

  2. Change from baseline Score at PTSD Checklist (self-assessment) for different dimensions of PTSD [inclusion ; 1 month; 3 months]

    Score at PTSD Checklist (self-assessment) for severity of different dimensions of PTSD

  3. Change from baseline Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A) [inclusion ; 1 month; 3 months]

    Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A)

  4. Change from baseline Score at depression item on Hamilton Anxiety Rating Scale (HAM-A) [inclusion ; 1 month; 3 months]

    Score at depression item on Hamilton Depression Rating Scale (HAM-D)

  5. Change from baseline heart rate [inclusion ; 1day ; 1 month, 3 months]

    heart rate

  6. Change from baseline electrodermal conductance [inclusion ; 1day ; 1 month, 3 months]

    electrodermal conductance measure

  7. Adverse effect [inclusion ; 1day ; 1 month, 3 months]

    Adverse effect

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • PCLS score >40

  • Able to give his written informed consent

  • Not participating another study

  • Affiliation to a social security system

  • Having a PTSD for 3 months

  • No treatment modification for 4 weeks (Psychotropic treatment or structured psychotherapy)

Exclusion Criteria:
  • Partially deaf with equipment

  • people with identified neurological disease

  • people with addiction to psychoactive substance

  • people who can't conform to tests

  • people having a contraindication for rTMS (cochlear implant )

  • people suffering from chronicle or acute delusional disorder

  • any circumstances making the people unable to understood nature, aim or consequences of the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Tours

Investigators

  • Principal Investigator: Wissam EL-HAGE, PhD, CHRU Tours

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Tours
ClinicalTrials.gov Identifier:
NCT02584894
Other Study ID Numbers:
  • PHAO 15- WEH / TETT- STIM
First Posted:
Oct 23, 2015
Last Update Posted:
Jul 10, 2020
Last Verified:
Jul 1, 2020

Study Results

No Results Posted as of Jul 10, 2020